Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 594
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2351CYP3A5P2RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.21) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2352LAMP2RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.20) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2353AQP3RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.19) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2354SEMA6CRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.19) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2355SATRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.18) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2356PTPRDRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.15) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2357MASP2RNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.15) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2358GADD45BRNAsHumanDownregulated in HCCs with PVI in comparison with HCCs without PVI (with Fisher ratio 1.14) PrognosticHCC with PVI v/s HCC without PVI p < 0.05Tissue17088983
2359RhoCProtein and RNAHumanUpregulated in highly invasive NHCC than in less invasive SLHCC and upregulated in EHML (Extrahepatic Metastatic Lesions) than HCC and PCLT (Pericarcinomatous liver tissues). PrognosticEHML (Extrahepatic Metastatic Lesions) v/s HCC and PCLT(pericarcinomatous liver tissues); increased RhoC expression strongly correlates with vein invasion p < 0.01Tissue15150600
2360PARD3, INSIG1, MPHOSPH9, SKP2, CUL4B, CETN2, ETS2, USH1C, PTPN11, OASL, ARL5, SMURF2, CDC42SE1, CSNK1G3, RACGAP1, DNAJC10, KCNK1, CDO1, CNGA1, NUDT9, GSTM3, SLC16A5, SARA2, ID2, MTHFD2L, SYNGR2, PRL10A, RNF130, MAFB, FLJ23749, LARP6, R3HDM, ZNF652, PGGT1B, HEXB, SLC27A2, ZBTB38, SH3GLB2, AGPAT3, GCHRNAsHumanDifferentially expressed between recurrence HCC disease PrognosticRecurrent v/s non-recurrent HCC p < 0.05Tissue17975138
2361UBA2RNAsHuman cell lineUpregulated in IFN-alpha drug-tolerant cells Potential Predictive *IFN-α treatment tolerant v/s non tolerant cells FDR <0.5%.Cell line 15709204
2362ZNF185RNAsHuman cell lineUpregulated in IFN-alpha drug-tolerant cells Potential Predictive *IFN-α treatment tolerant v/s non tolerant cells FDR <0.5%.Cell line 15709204
2363FOXF1RNAsHuman cell lineUpregulated in IFN-alpha drug-tolerant cells Potential Predictive *IFN-α treatment tolerant v/s non tolerant cells FDR <0.5%.Cell line 15709204
2364UBE4BRNAsHuman cell lineDownregulated in IFN-alpha drug-tolerant cells Potential Predictive *IFN-α treatment tolerant v/s non tolerant cells FDR <0.5%.Cell line 15709204
2365PFKFB1RNAsHumanUpregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2366G6PCRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2367PCK1RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2368Fructose-1,6-biphosphataseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2369NADH dehydrogenase Fe-S protein 8RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2370NADH dehydrogenase 1-alpha subcomplexRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2371NADH dehydrogenase Fe-S protein 6RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2372PDHA1/A2/BRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2373GALK1RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2374GALK2RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2375ALDOBRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2376UGP2RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2377GYS2RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2378LAP3RNAsHumanUpregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2379Alanine:glyoxylate aminotransferaseRNAsHumanUpregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2380Carbamyl phosphate synthetase IRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2381Phenylalanine hydroxylaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2382Kynurenine 3-hydroxylaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2383Ornithine decarboxylaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2384PrealbuminRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2385Serum albuminRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2386TransferrinRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2387FGARNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2388FGBRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2389Alpha-1 type XVI collagenRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2390Alpha-1 type XVI collagenRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2391Antithrombin IIIRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2392Coagulation factor XIIIRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2393CeruloplasminRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2394CRPRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2395Ferritin HRNAsHumanUpregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2396AFPRNAsHumanUpregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2397Acyl-coenzyme A:cholesterol acyltransferase 1RNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
23987-Dehydrocholesterol reductaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2399CTP:phosphocholinecytidyl transferaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456
2400Acyl-CoA dehydrogenaseRNAsHumanDownregulated in HCC than non-tumor DiagnosticHCC v/s non-tumor p < 0.05Tissue11752456

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top